- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
During the treatment with pomalidomide, it is important to focus on preventing bone marrow suppression, venous thrombosis, liver toxicity, and ...
Pomalidomide is a treatment drug for multiple myeloma, and standardized medication and monitoring are key to ensuring efficacy and safety. 1...
During the treatment with pomalidomide, fatigue, constipation, and peripheral neuropathy may occur. Scientific management can alleviate discomf...
Pomalidomide is an immunomodulatory agent, and its administration and dosage adjustment directly affect its efficacy and safety. It is necessar...
During the use of deuteroxenib, special attention should be paid to the risk of infection, hepatotoxicity, and drug interactions. The following...
Deucravatinib is not suitable for all patients. Individuals with active severe infections and severe liver dysfunction should be particularly v...
During the treatment with deuteroxenib, some patients may experience upper respiratory tract infections, acne, or fatigue. The following are th...
Deucravatinib is an oral targeted drug, and standardized medication is the basis for ensuring efficacy and safety. The following are specific p...
Nadimeidine can effectively improve constipation caused by opioid drugs, but serious risks should be monitored during medication. Mastering the...
Identifying taboo groups is the primary step in ensuring medication safety. The use of this product is strictly prohibited in the following thr...
